A novel cancer-germline transcript carrying pro-metastatic miR-105 and TET-targeting miR-767 induced by DNA hypomethylation in tumors

Epigenetics

Volumn 9, Issue 8, 2014, Pages 1163-1171

  Loriot, Axelle ^a   Van tongelen, Aurélie ^a   Blanco, Jordi ^a   Klaessens, Simon ^a   Cannuyer, Julie ^a   van Baren, Nicolas ^b   Decottignies, Anabelle ^a   De Smet, Charles ^a  

^a DE DUVE INSTITUTE   (Belgium)

^b CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

Author keywords

Cancer epigenetics; Cancer germline or cancer testis genes; DNA methylation; MicroRNAs; TET genes

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; DIOXYGENASE; DNA BINDING PROTEIN; GABRA3 PROTEIN, HUMAN; MESSENGER RNA; MICRORNA; MIRN-767 MICRORNA, HUMAN; MIRN105 MICRORNA, HUMAN; ONCOPROTEIN; TET1 PROTEIN, HUMAN; TET3 PROTEIN, HUMAN;

DNA METHYLATION; GENETICS; HUMAN; METABOLISM; METASTASIS; NEOPLASM; PATHOLOGY; TUMOR CELL LINE;

CELL LINE, TUMOR; DIOXYGENASES; DNA METHYLATION; DNA-BINDING PROTEINS; HUMANS; MICRORNAS; NEOPLASM METASTASIS; NEOPLASMS; PROTO-ONCOGENE PROTEINS; RECEPTORS, GABA-A; RNA, MESSENGER;

EID: 84905648854     PISSN: 15592294     EISSN: 15592308     Source Type: Journal    
DOI: 10.4161/epi.29628     Document Type: Article

References (41)

1. Bird A. DNA methylation patterns and epigenetic memory. Genes Dev 2002; 16:6-21; PMID:11782440; http://dx.doi.org/10.1101/ gad.947102
2. Jones PA, Baylin SB. The fundamental role of epigenetic events in cancer. Nat Rev Genet 2002; 3:415-28; PMID:12042769
3. De Smet C, Loriot A. DNA hypomethylation and activation of germline-specific genes in cancer. Adv Exp Med Biol 2013; 754:149-66; PMID:22956500; http://dx.doi.org/10.1007/978-1-4419-9967-2_7
4. Simpson AJ, Caballero OL, Jungbluth A, Chen YT, Old LJ. Cancer/testis antigens, gametogenesis and cancer. Nat Rev Cancer 2005; 5:615-25; PMID:16034368; http://dx.doi.org/10.1038/ nrc1669
5. Cannuyer J, Loriot A, Parvizi GK, De Smet C. Epigenetic hierarchy within the MAGEA1 cancer-germline gene: promoter DNA methylation dictates local histone modifications. PLoS One 2013; 8:e58743; PMID:23472218; http://dx.doi. org/10.1371/journal.pone.0058743
6. De Smet C, Lurquin C, Lethé B, Martelange V, Boon T. DNA methylation is the primary silencing mechanism for a set of germ line-and tumor-specific genes with a CpG-rich promoter. Mol Cell Biol 1999; 19:7327-35; PMID:10523621
7. Croce CM. Causes and consequences of microRNA dysregulation in cancer. Nat Rev Genet 2009; 10:704-14; PMID:19763153; http://dx.doi.org/10.1038/ nrg2634
8. Melo SA, Esteller M. Dysregulation of microRNAs in cancer: playing with fire. FEBS Lett 2011; 585:2087-99; PMID:20708002; http://dx.doi.org/10.1016/j. febslet.2010.08.009
9. Liu Y, Guo F, Dai M, Wang D, Tong Y, Huang J, Hu J, Li G. Gammaaminobutyric acid A receptor alpha 3 subunit is overexpressed in lung cancer. Pathol Oncol Res 2009; 15:351-8; PMID:19048400; http:// dx.doi.org/10.1007/s12253-008-9128-7
10. Liu Y, Li YH, Guo FJ, Wang JJ, Sun RL, Hu JY, Li GC. Gamma-aminobutyric acid promotes human hepatocellular carcinoma growth through overexpressed gamma-aminobutyric acid A receptor alpha 3 subunit. World J Gastroenterol 2008; 14:7175-82; PMID:19084931; http://dx.doi.org/10.3748/ wjg.14.7175
11. Lu Y, Lemon W, Liu PY, Yi Y, Morrison C, Yang P, Sun Z, Szoke J, Gerald WL, Watson M, et al. A gene expression signature predicts survival of patients with stage I non-small cell lung cancer. PLoS Med 2006; 3:e467; PMID:17194181; http://dx.doi.org/10.1371/ journal.pmed.0030467
12. Zhang X, Zhang R, Zheng Y, Shen J, Xiao D, Li J, Shi X, Huang L, Tang H, Liu J, et al. Expression of gammaaminobutyric acid receptors on neoplastic growth and prediction of prognosis in non-small cell lung cancer. J Transl Med 2013; 11:102; PMID:23617850; http:// dx.doi.org/10.1186/1479-5876-11-102
13. Zhou W, Fong MY, Min Y, Somlo G, Liu L, Palomares MR, Yu Y, Chow A, O'Connor ST, Chin AR, et al. Cancer-secreted miR-105 destroys vascular endothelial barriers to promote metastasis. Cancer Cell 2014; 25:501-15; PMID:24735924; http:// dx.doi.org/10.1016/j.ccr.2014.03.007
14. Pfeifer GP, Kadam S, Jin SG. 5-hydroxymethylcytosine and its potential roles in development and cancer. Epigenetics Chromatin 2013; 6:10; PMID:23634848; http://dx.doi.org/10.1186/1756-8935-6-10
15. Ito S, D'Alessio AC, Taranova OV, Hong K, Sowers LC, Zhang Y. Role of Tet proteins in 5mC to 5hmC conversion, ES-cell self-renewal and inner cell mass specification. Nature 2010; 466:1129-33; PMID:20639862; http://dx.doi.org/10.1038/ nature09303
16. Tahiliani M, Koh KP, Shen Y, Pastor WA, Bandukwala H, Brudno Y, Agarwal S, Iyer LM, Liu DR, Aravind L, et al. Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1. Science 2009; 324:930-5; PMID:19372391; http://dx.doi.org/10.1126/ science.1170116
17. Ko M, Huang Y, Jankowska AM, Pape UJ, Tahiliani M, Bandukwala HS, An J, Lamperti ED, Koh KP, Ganetzky R, et al. Impaired hydroxylation of 5-methylcytosine in myeloid cancers with mutant TET2. Nature 2010; 468:839-43; PMID:21057493; http:// dx.doi.org/10.1038/nature09586
18. Lian CG, Xu Y, Ceol C, Wu F, Larson A, Dresser K, Xu W, Tan L, Hu Y, Zhan Q, et al. Loss of 5-hydroxymethylcytosine is an epigenetic hallmark of melanoma. Cell 2012; 150:1135-46; PMID:22980977; http://dx.doi.org/10.1016/j.cell.2012.07.033
19. Yang H, Liu Y, Bai F, Zhang JY, Ma SH, Liu J, Xu ZD, Zhu HG, Ling ZQ, Ye D, et al. Tumor development is associated with decrease of TET gene expression and 5-methylcytosine hydroxylation. Oncogene 2013; 32:663-9; PMID:22391558; http://dx.doi. org/10.1038/onc.2012.67
20. Figueroa ME, Abdel-Wahab O, Lu C, Ward PS, Patel J, Shih A, Li Y, Bhagwat N, Vasanthakumar A, Fernandez HF, et al. Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation. Cancer Cell 2010; 18:553-67; PMID:21130701; http://dx.doi.org/10.1016/j. ccr.2010.11.015
21. Hsu CH, Peng KL, Kang ML, Chen YR, Yang YC, Tsai CH, Chu CS, Jeng YM, Chen YT, Lin FM, et al. TET1 suppresses cancer invasion by activating the tissue inhibitors of metalloproteinases. Cell Rep 2012; 2:568-79; PMID:22999938; http://dx.doi. org/10.1016/j.celrep.2012.08.030
22. Cheng J, Guo S, Chen S, Mastriano SJ, Liu C, D'Alessio AC, Hysolli E, Guo Y, Yao H, Megyola CM, et al. An extensive network of TET2-targeting MicroRNAs regulates malignant hematopoiesis. Cell Rep 2013; 5:471-81; PMID:24120864; http:// dx.doi.org/10.1016/j.celrep.2013.08.050
23. Song SJ, Ito K, Ala U, Kats L, Webster K, Sun SM, Jongen-Lavrencic M, Manova-Todorova K, Teruya-Feldstein J, Avigan DE, et al. The oncogenic microRNA miR-22 targets the TET2 tumor suppressor to promote hematopoietic stem cell self-renewal and transformation. Cell Stem Cell 2013; 13:87-101; PMID:23827711; http://dx.doi.org/10.1016/j. stem.2013.06.003
24. Song SJ, Poliseno L, Song MS, Ala U, Webster K, Ng C, Beringer G, Brikbak NJ, Yuan X, Cantley LC, et al. MicroRNA-antagonism regulates breast cancer stemness and metastasis via TET-family-dependent chromatin remodeling. Cell 2013; 154:311-24; PMID:23830207; http://dx.doi.org/10.1016/j. cell.2013.06.026
25. Moran-Crusio K, Reavie L, Shih A, Abdel-Wahab O, Ndiaye-Lobry D, Lobry C, Figueroa ME, Vasanthakumar A, Patel J, Zhao X, et al. Tet2 loss leads to increased hematopoietic stem cell selfrenewal and myeloid transformation. Cancer Cell 2011; 20:11-24; PMID:21723200; http://dx.doi. org/10.1016/j.ccr.2011.06.001
26. Quivoron C, Couronné L, Della Valle V, Lopez CK, Plo I, Wagner-Ballon O, Do Cruzeiro M, Delhommeau F, Arnulf B, Stern MH, et al. TET2 inactivation results in pleiotropic hematopoietic abnormalities in mouse and is a recurrent event during human lymphomagenesis. Cancer Cell 2011; 20:25-38; PMID:21723201; http://dx.doi.org/10.1016/j. ccr.2011.06.003
27. Zha R, Guo W, Zhang Z, Qiu Z, Wang Q, Ding J, Huang S, Chen T, Gu J, Yao M, et al. Genome-wide screening identified that miR-134 acts as a metastasis suppressor by targeting integrin β1 in hepatocellular carcinoma. PLoS One 2014; 9:e87665; PMID:24498348; http://dx.doi.org/10.1371/journal. pone.0087665
28. Williams K, Christensen J, Helin K. DNA methylation: TET proteins-guardians of CpG islands? EMBO Rep 2012; 13:28-35; PMID:22157888; http://dx.doi.org/10.1038/embor.2011.233
29. Hackett JA, Sengupta R, Zylicz JJ, Murakami K, Lee C, Down TA, Surani MA. Germline DNA demethylation dynamics and imprint erasure through 5-hydroxymethylcytosine. Science 2013; 339:448-52; PMID:23223451; http://dx.doi.org/10.1126/ science.1229277
30. Yamaguchi S, Shen L, Liu Y, Sendler D, Zhang Y. Role of Tet1 in erasure of genomic imprinting. Nature 2013; 504:460-4; PMID:24291790; http://dx.doi. org/10.1038/nature12805
31. Gjerstorff MF, Kock K, Nielsen O, Ditzel HJ. MAGE-A1, GAGE and NY-ESO-1 cancer/testis antigen expression during human gonadal development. Hum Reprod 2007; 22:953-60; PMID:17208940; http://dx.doi.org/10.1093/humrep/del494
32. Koslowski M, Bell C, Seitz G, Lehr HA, Roemer K, Müntefering H, Huber C, Sahin U, Türeci O. Frequent nonrandom activation of germ-line genes in human cancer. Cancer Res 2004; 64:5988-93; PMID:15342378; http://dx.doi.org/10.1158/0008-5472.CAN-04-1187
33. Maatouk DM, Kellam LD, Mann MR, Lei H, Li E, Bartolomei MS, Resnick JL. DNA methylation is a primary mechanism for silencing postmigratory primordial germ cell genes in both germ cell and somatic cell lineages. Development 2006; 133:3411-8; PMID:16887828; http://dx.doi.org/10.1242/ dev.02500
34. Jin SG, Wu X, Li AX, Pfeifer GP. Genomic mapping of 5-hydroxymethylcytosine in the human brain. Nucleic Acids Res 2011; 39:5015-24; PMID:21378125; http://dx.doi.org/10.1093/nar/ gkr120
35. Kaas GA, Zhong C, Eason DE, Ross DL, Vachhani RV, Ming GL, King JR, Song H, Sweatt JD. TET1 controls CNS 5-methylcytosine hydroxylation, active DNA demethylation, gene transcription, and memory formation. Neuron 2013; 79:1086-93; PMID:24050399; http://dx.doi.org/10.1016/j. neuron.2013.08.032
36. Rudenko A, Dawlaty MM, Seo J, Cheng AW, Meng J, Le T, Faull KF, Jaenisch R, Tsai LH. Tet1 is critical for neuronal activity-regulated gene expression and memory extinction. Neuron 2013; 79:1109-22; PMID:24050401; http://dx.doi.org/10.1016/j. neuron.2013.08.003
37. Loriot A, Parvizi GK, Reister S, De Smet C. Silencing of cancer-germline genes in human preimplantation embryos: evidence for active de novo DNA methylation in stem cells. Biochem Biophys Res Commun 2012; 417:187-91; PMID:22155245; http://dx.doi. org/10.1016/j.bbrc.2011.11.120
38. Davis LG, Dibner MD, Battey JF. Basic methods in molecular biology. New York: Elsevier, 1986.
39. De Smet C, Loriot A, Boon T. Promoter-dependent mechanism leading to selective hypomethylation within the 5′ region of gene MAGE-A1 in tumor cells. Mol Cell Biol 2004; 24:4781-90; PMID:15143172; http://dx.doi.org/10.1128/ MCB.24.11.4781-4790.2004
40. De Smet C, De Backer O, Faraoni I, Lurquin C, Brasseur F, Boon T. The activation of human gene MAGE-1 in tumor cells is correlated with genomewide demethylation. Proc Natl Acad Sci U S A 1996; 93:7149-53; PMID:8692960; http://dx.doi. org/10.1073/pnas.93.14.7149
41. Cancer Genome Atlas Research Network. Comprehensive genomic characterization of squamous cell lung cancers. Nature 2012; 489:519-25; PMID:22960745; http://dx.doi.org/10.1038/ nature11404